| Literature DB >> 33087777 |
Zhenlu Li1,2, Ailin Wei1,3, Ning Xia2, Liangxia Zheng4, Dujiang Yang2,5,6, Jun Ye7, Junjie Xiong8, Weiming Hu9.
Abstract
Postoperative pancreatic fistula (POPF) is the most serious complication after pancreaticoduodenectomy (PD). Recently, Blumgart anastomosis (BA) has been found to have some advantages in terms of decreasing POPF compared with other pancreaticojejunostomy (PJ) using either the duct-to-mucosa or invagination approach. Therefore, the aim of this study was to examine the safety and effectiveness of BA versus non-Blumgart anastomosis after PD. The PubMed, EMBASE, Web of Science and the Cochrane Central Library were systematically searched for studies published from January 2000 to March 2020. One RCT and ten retrospective comparative studies were included with 2412 patients, of whom 1155 (47.9%) underwent BA and 1257 (52.1%) underwent non-Blumgart anastomosis. BA was associated with significantly lower rates of grade B/C POPF (OR 0.38, 0.22 to 0.65; P = 0.004) than non-Blumgart anastomosis. Additionally, in the subgroup analysis, the grade B/C POPF was also reduced in BA group than the Kakita anastomosis group. There was no significant difference regarding grade B/C POPF in terms of soft pancreatic texture between the BA and non-Blumgart anastomosis groups. In conclusion, BA after PD was associated with a decreased risk of grade B/C POPF. Therefore, BA seems to be a valuable PJ to reduce POPF comparing with non-Blumgart anastomosis.Entities:
Mesh:
Year: 2020 PMID: 33087777 PMCID: PMC7578105 DOI: 10.1038/s41598-020-74812-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1PRISMA diagram showing selection of articles for review BA Blumgart anastomosis, PG pancreaticogastrostomy.
Study characteristics.
| Author | Year | Country | Design | Group | No of patient | Age# | BMI# | Disease | Types of surgery | PV/SMV resection | Soft texture | Stent | O | MPD (N/D) | Score* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kleespies | 2009 | Germany | Retro | BA CWA | 92(52) 90(53) | 66.5(23–82) 65 (21–78) | NA | BMDPP | PD and PPPD | NA | NA | No | S | NA | 2 |
| Fujii | 2014 | Japan | Retro | BA KA | 120(74) 120(75) | 64.9(38–84) 66.0(18–83) | NA | BMDPP | PD,SSPPD and PPPD | 45 40 | 45 45 | Ex. S | NA | 57/63 50/70 | 2 |
| Oda | 2015 | Japan | Retro | BA KA | 78(51) 78 (50) | 66 ± 10 63 ± 13 | NA | BMDPP | PD | 18 11 | 55 58 | No Ex S | NA | 39/39 36/42 | 2 |
| Kawakatsu | 2018 | Japan | Retro | BA KA | 110(66) 176(10) | 69 (21–86) 66 (32–87) | 22.2(16.1–31.6) 22.3(15.9–32.0) | BMDPP | SSPPD | NA | 100 100 | Ex | NA | NA | 2 |
| Kojima | 2018 | Japan | Retro | BA CWA KA | 101(56) 103(55) 170(85) | 71 (47–87) 68 (28–88) 70 (33–90) | NA | BMDPP | PD,SSPPD and PPPD | 28 10 23 | 59 44 56 | Ex/In Ex Ex | No | 42/58 56/47 87/83 | 2 |
| Lee | 2018 | Korea | Retro | BA DtoM/CWA | 43(25) 44(33) | 67.00 ± 8.06 63.14 ± 10.67 | 24.72 ± 3.77 22.22 ± 2.91 | BMDPP | PD and PPPD | 5 2 | NA | S | S | NA | 2 |
| Satoi | 2019 | Japan | Retro | BA KA | 118(80) 128(73) | 72 (32–86) 69 (33–87) | NA | BMDPP | PD | NA | 59 52 | No | S | 51/67 57/71 | 2 |
| Hirono | 2019 | Japan | RCT | BA CWA + KA | 107(59) 103(62) | 68 (24–90) 70 (40–86) | 22.2(14.9–35.1) 21.6 (16.1–29.4) | BMDPP | PD and PPPD | 23 24 | 57 56 | In In | S | NA | Unclear risk |
| Ya-Tong Li | 2019 | China | Retro | BA EA | 201(109) 90(41) | 53.28 ± 19.14 54.54 ± 17.18 | NA | BMDPP | PD | NA | 16 17 | S | NA | NA | 2 |
| Rentao | 2019 | China | Retro | BA EA + DtoM | 148(45) 81(45) | 62.5(26–86) 60 (27–74) | NA | BMDPP | PD and PPPD | 2 4 | 48 44 | In NA | NA | NA | 2 |
| Casadei | 2020 | Italy | Retro | BA DtoM/CWA | 37(22) 37(23) 37(22) | 68.2 ± 10.4 68.2 ± 9.2 69.8 ± 10.5 | 24.9 ± 3.8 25.5 ± 3.8 24.9 ± 3.1 | BMDPP | PD | 0 0 0 | 60 49 57 | NA | S | 21/16 19/18 23/14 | 2 |
BMI, Body Mass Index; PV, portal vein; SMV, superior mesenteric vein; O, octreotide; MPD(N/D), main pancreatic duct(Non-dilated/dilated); BA, Blumgart anastomosis; CWA, Cattell–Warren anastomosis; KA, Kakita anastomosis; NA, Data not available; BMDPP, benign and malignant disease of the pancreatic head and the periampullary region; PD, pancreaticoduodenectomy; PPPD, pylorus-preserving pancreatoduodenectomy; SSPPD, subtotal stomach-preserving pancreatoduodenectomy; S, Select; Ex, external stent; In, internal stent; RCT, Randomized Controlled Trial; EA, Embedded anastomosis; DtoM, duct-to-mucosa anastomosis.
#Data was recorded as Mean ± SD or median (range).
*Randomized clinical trials (RCTs) were scored according to the RoB 2.0 of the Cochrane Collaboration; the method of McKay and colleagues was used for non-randomized studies.
Surgical technique and definition of pancreatic fistula.
| Author | Pancreaticojejunostomy technique | Definition of pancreatic fistula |
|---|---|---|
| Kleespies et al.[ | BA: Four U-sutures, ES (DM)-PJ CWA: ES (DM)-PJ | ISGPF definition (2005) |
| Fujii et al.[ | BA: ES (DM)-PJ, wide U-shape suture KA: ES (DM)-PJ | ISGPF definition (2005) |
| Oda et al.[ | mBA: ES (DM)-PJ, three double-armed U-sutures KA: ES (DM)-PJ | ISGPF definition (2005) |
| Kawakatsu et al.[ | mBA: ES (DM)-PJ, two or three double-armed horizontal mattress sutures and one of the sutures strode across the main pancreatic duct to bind it mKA: ES (DM)-PJ, two or three double-armed penetrating sutures | ISGPF definition (2005) |
| Kojima et al.[ | mBA: three U-sutures tied at the ventral wall of the jejunum; and the use of peritoneal lavage, closed drains and dressing materials to cover the wound and drains; ES (DM)-PJ CWA: ES (DM)-PJ mKA: ES (DM)-PJ | ISGPF definition (2005) |
| Lee et al.[ | BA: ES (DM)-PJ CWA: ES (DM)-PJ | ISGPF definition (2005) |
| Satoi et al.[ | mBA: ES (DM)-PJ, Two U-sutures placed 0.5 cm apart from the main pancreatic duct mKA: ES (DM)-PJ, two non-absorbable interrupted penetrating sutures | ISGPF definition (2005) |
| Hirono et al.[ | mBA: ES (DM)-PJ, tie knots on the ventral wall of the jejunum CWA/KA: ES (DM)-PJ, 4 trans-pancreatic sutures on KA; single layer of 8 or more sutures on CWA | ISGPF definition (2017) |
| Ya-Tong Li et al.[ | BA: ES (DM)-PJ Embedded: EE (MM)-PJ | ISGPF definition (2017) |
| Rentao Li et al.[ | BA/mBA: Blumgart anastomosis and its modification (superimposed the backwall sutures on each other omitted the DM anastomosis, ES (DM)-PJ In/ DtoM: EE (MM)-PJ or ES (DM)-PJ | ISGPF definition (2017) |
| Casadei et al.[ | BA: ES (DM)-PJ DtoM: ES (DM)-PJ In: EE (MM)-PJ | ISGPF definition (2017) |
ES, end-to-side; EE, end-to-end; DM, duct-to-mucosa; MM, mucosa-to-mucosa; IN, invagination; PJ, pancreaticojejunostomy; ISGPF, the International Study Group of Pancreatic Surgery; BA, Blumgart anastomosis; KA, Kakita anastomosis; CWA, Cattell–Warren anastomosis; DtoM, duct-to-mucosa anastomosis.
Figure 2The forest plot of primary outcomes in Blumgart group versus non-Blumgart group.
Results of meta-analysis comparing Blumgart group with non-Blumgart group.
| Outcome of interest | Study | Patient | Effect estimate | Heterogeneity | ||
|---|---|---|---|---|---|---|
| OR/WMD (95%CI) | ||||||
| POPF(B/C) | 11 | 2142 | 0.38 (0.22, 0.65) | 76 | < 0.0001 | |
| Grade C pancreatic fistula | 7 | 1370 | 0.52 (0.27, 1.02) | 22 | 0.27 | |
| POPF(B/C) (2017 ISGPF) | 4 | 841 | 0.58 (0.39, 0.87) | 46 | 0.14 | |
| POPF(B/C) in soft pancreas | 4 | 695 | 0.46(0.14,1.53) | 87 | < 0.0001 | |
| Operative time | 9 | 1927 | − 9.80 (− 35.81,16.20) | 88 | < 0.00001 | |
| Kojima-CWA | 10 | 2131 | − 54.11 (− 221.63,113.42) | 95 | < 0.00001 | |
| Kojima-KA | 10 | 2198 | − 53.87 (− 220.69,112.95) | 95 | < 0.00001 | |
| Postoperative hemorrhage | 8 | 1881 | 0.48(0.29,0.79) | 0 | 0.44 | |
| Hemorrhage(B/C) | 5 | 479 | 0.33(0.12,0.89) | 6 | 0.35 | |
| DGE | 4 | 947 | 0.76 (0.45,1.30) | 76 | 0.006 | |
| DGE (B/C) | 4 | 853 | 1.05 (0.68,1.62) | 58 | 0.07 | |
| Bile leakage | 6 | 1403 | 0.70(0.33,1.51) | 0 | 0.63 | |
| Intra-abdominal abscess | 8 | 1859 | 0.53 (0.39,0.72) | < | 16 | 0.3 |
| Wound infection | 6 | 1358 | 0.65 (0.37,1.14) | 58 | 0.04 | |
| Morbidity | 10 | 2183 | − 0.12 (− 0.21, − 0.04) | 80 | < 0.00001 | |
| Major morbidity | 6 | 1518 | 0.67 (0.43,1.04) | 72 | 0.01 | |
| Mortality | 8 | 1599 | 0.51 (0.21,1.26) | 0 | 0.9 | |
| Reoperation | 9 | 1951 | 0.50 (0.30,0.81) | 0 | 0.9 | |
| Kojima-CWA | 11 | 2212 | − 3.89 (− 7.45, − 0.32) | 89 | < 0.00001 | |
| Kojima-KA | 11 | 2309 | − 4.28 (− 7.35, − 1.21) | 84 | < 0.00001 | |
WMD, Weight mean difference; POPF, postoperative pancreatic fistula; DGE, delayed gastric emptying.
Results of subgroup analysis.
| Outcome of interest | Study | Patient | Effect estimate | Heterogeneity | ||
|---|---|---|---|---|---|---|
| OR/WMD = (95%CI) | P | I2% | P | |||
| POPF(B/C) | 4 | 547 | 0.28 (0.15, 0.52) | < 0.0001 | 41% | 0.17 |
| Grade C pancreatic fistula | 2 | 161 | 0.19 (0.03, 1.09) | 0.06 | 48% | 0.17 |
| Operative time | 2 | 269 | − 57.99 (− 114.22,1.76) | 0.04 | 81% | 0.02 |
| Blood loss | 3 | 473 | − 255.09 (− 695.01, − 184.83) | 0.26 | 89% | 0.0002 |
| Postoperative hemorrhage | 3 | 473 | 0.29 (0.12,0.72) | 0.008 | 0% | 0.64 |
| DGE | 2 | 291 | 0.26 (0.10,0.68) | 0.006 | 0% | 0.9 |
| Bile leakage | 3 | 473 | 0.63 (0.21,1.88) | 0.41 | 0% | 0.54 |
| Intra-abdominal abscess | 3 | 473 | 0.53 (0.29,0.98) | 0.04 | 2% | 0.36 |
| Wound infection | 3 | 473 | 0.44 (0.09,2.21) | 0.32 | 83% | 0.003 |
| Morbidity | 2 | 269 | 0.64 (0.27, 1.54) | 0.32 | 64% | 0.09 |
| Major morbidity | 2 | 278 | 0.18 (0.01,3.38) | 0.25 | 76% | 0.04 |
| Mortality | 3 | 297 | 0.18 (0.05, 0.65) | 0.009 | 0% | 0.97 |
| Reoperation | 2 | 210 | 0.16 (0.06, 0.42) | 0.0002 | 0% | 0.9 |
| Postoperative hospital stay | 2 | 291 | − 4.81 (− 21.66, 12.05) | 0.58 | 93% | 0.0001 |
| POPF (B/C) | 5 | 1199 | 0.26 (0.09,0.74) | 0.01 | 89% | < 0.00001 |
| POPF (B/C) in soft pancreas | 3 | 531 | 0.30 (0.07,1.39) | 0.12 | 90% | < 0.0001 |
| Grade C pancreatic fistula | 2 | 442 | 1.11 (0.41,2.99) | 0.84 | 35% | 0.21 |
| Operative time | 4 | 928 | − 19.08 (− 32.11, − 6.05) | 0.004 | 45% | 0.14 |
| Blood loss | 5 | 1199 | − 34.28 (− 62.35, − 6.02) | 0.02 | 0% | 0.63 |
| Postoperative hemorrhage | 4 | 959 | 0.58 (0.21,1.60) | 0.29 | 27% | 0.25 |
| DGE | 3 | 757 | 0.81 (0.18,3.52) | 0.77 | 72% | 0.03 |
| Intra-abdominal abscess | 3 | 757 | 0.36 (0.23,0.56) | < 0.00001 | 0% | 0.89 |
| Wound infection | 3 | 757 | 0.44 (0.28,0.69) | 0.004 | 69% | 0.04 |
| Morbidity | 2 | 396 | 065 (032,1.35) | 0.25 | 92% | 0.0005 |
| Major morbidity | 2 | 517 | 0.72 (0.20,2.65) | 0.63 | 89 | 0.003 |
| Mortality | 4 | 928 | 0.91 (0.20,4.08) | 0.9 | 0% | 0.63 |
| Reoperation | 4 | 928 | 0.68 (0.22,2.09 | 0.5 | 0% | 0.89 |
| Postoperative hospital stay | 5 | 1199 | − 6.44 (− 12.50, − 0.39) | 0.04 | 90% | < 0.00001 |
| POPF (B/C) | 2 | 365 | 0.43 (0.21, 0.76) | 0.004 | 0% | 0.67 |
| Grade C pancreatic fistula | 2 | 365 | 0.24 (0.06, 0.89) | 0.03 | 0% | 0.86 |
| Severe morbidity | 2 | 365 | 0.11 (0.01, 2.46) | 0.17 | 78% | 0.03 |
| Mortality | 2 | 365 | 0.38 (0.05, 3.12) | 0.37 | 0% | 0.88 |
| Reoperation | 2 | 365 | 0.41 (0.18, 0.90) | 0.03 | 0% | 0.57 |
| Postoperative hospital stay | 2 | 365 | − 9.80 (− 15.19, − 4.14) | 0.0004 | 80% | 0.003 |
WMD, Weight mean difference; POPF, postoperative pancreatic fistula; DGE, Delayed gastric emptying; ICU, Intensive Care Unit; Major morbidity, Clavien-Dindo grade ≥ 3 complications.
Figure 3Funnel plot to investigate publication bias basing on POPF.
Summary of excluded literature reports for Blumgart Anastomosis.
| Study | Year | Country | Group | No of patient | Age | Soft texture (%) | CR-POPF (%) | PPH (%) | Morbidity (%) | Mortality (%) | POHS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Grobmyer et al[ | 2010 | USA | BA | 187 | 63 (23–85) | 47 | 6.9 | 3.2 | 1.6 | 1.6 | 10 (7–58) |
| Mishra et al[ | 2011 | India | BA | 98 | 48.6 (16–76) | 43.9 | 7.14 | 5.1 | 39.8 | 3.06 | 13 (6–41) |
| Kim et al[ | 2014 | Korea | BA | 20 | 63.5 ± 9.7 | NA | 10 | 10.0 | 20.0 | 0 | 21.5 ± 7.0 |
| Wang et al[ | 2016 | China | BA | 103 | 65 (30–87) | NA | 20 | 12 | 49.0 | 0 | 25 (10–99) |
| Poves et al[ | 2017 | Spain | OBA | 13 | 67 ± 10.5 | 76.9 | 30.8 | 15.4 | 84.6 | 0 | 21 (13.5–42.5) |
| LBA | 13 | 65 ± 11.8 | 76.9 | 15.4 | 7.7 | 69.2 | 0 | 14 (7.5–15.5) | |||
| Lee WJ et al[ | 2018 | Korea | BA | 11 | NA | NA | 0 | NA | NA | 0 | NA |
| Wang et al.[ | 2018 | China | OBA | 87 | NA | 55.2 | 8.0 | 3.4 | 43.7 | NA | 24 (7–77) |
| RBA | 52.9 | 12.6 | 13.8 | 37.9 | 24 (9–136) | ||||||
| Wang et al[ | 2018 | China | cBA | 97 | NA | 40.2 | 10.3 | 0 | 55.5 | 1.0 | 22 ± 10 |
| mBA | 50 | 50.0 | 12.0 | 0 | 40 | 0 | 23 ± 8 | ||||
| Gupta et al[ | 2019 | India | BA | 81 | 48.04 ± 10.14 | 45.7 | 12.3 | 13.6 | 51.9 | NA | 15 (7–65) |
| Kim et al[ | 2019 | Korea | mBA | 50 | 67.2 ± 3.6 | 24.0 | 10 | 4.0 | 10.0 | 2.0 | 19.5 ± 2.6 |
| Tewari et al[ | 2019 | India | BA | 150 | 51.2 ± 10 | 74.6 | 0.67 | NA | NA | 0 | 7.3 ± 4.2 |
| Nagakawa et al[ | 2020 | Japan | LBA | 20 | 62.1 ± 16.8 | 95.0 | 20.0 | NA | 25.0 | NA | 23.9 ± 15.6 |
| LBA with clips | 19 | 60.4 ± 17.3 | 100 | 21.1 | 26.3 | 22.1 ± 12.1 |
Data was recorded as Mean ± SD or median (range).
BA, Blumgart anastomosis; OBA, open pancreaticoduodenectomy with Blumgart anastomosis; LBA, laparoscopic pancreaticoduodenectomy with Blumgart anastomosis; RBA, robotic pancreaticoduodenectomy with Blumgart anastomosis; cBA, conventional Blumgart anastomosis; mBA, modified Blumgart anastomosis; POHS, postoperative hospital stay; NA, Data not available, CR-POPF, clinically relevant postoperative pancreatic fistula; PPH, postoperative hemorrhage.